- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04826861
Supporting Lifestyle Change in Obese Pregnant Mothers Through Wearable Internet-of-Things (SLIM) (SLIM)
Development and Implementation of Supporting Lifestyle Change in Obese Pregnant Mothers Through Wearable Internet-of-Things (SLIM) Intervention
Maternal obesity increases risks for the mother and her child. It is crucial to arouse the pregnant and postpartum women´s willingness of change and motivation to take care of their own and their unborn child´s health. Wearable devices can be helpful for weight-management, e.g. in improving participant's self-efficacy in making healthy behavior changes, improving self-awareness, in goal setting and getting feedback. More comprehensive research is required to implement the optimal weight-management intervention for overweight women during pregnancy and the postpartum period and to develop appropriate and feasible implementation strategies to support nurses to deliver interventions in maternity clinics.
The aim of this study is to evaluate the effectiveness of the Supporting Lifestyle Change in Obese Pregnant Mothers Through Wearable Internet-of-Things (SLIM) intervention. Secondary aim is to evaluate the implementation of SLIM intervention in maternity care.
Intervention was developed based on findings of overweight women and their care givers interview study. The intervention targeting overweight pregnant women to improve their weight-management will be delivered during routine perinatal visits from the first visit to three months after child birth. Interventions core components will be goalsetting, motivational interviewing, feedback and health technology. Health technology includes Oura-ring and ZotCare -application. ZotCare -application combines data from Oura Smart Ring, electronic food diary and it´s also platform for researchers to send e.g. questionnaires and surveys to participants. Oura-smartring is an advanced technology ring that monitors e.g. heart rate, heart rate variability (HRV), steps, body temperature and sleep) and a smartphone application that includes data from Oura, and electronic food diary. Data collected with Oura -smartrings will be transmitted to cloud servers via a smartphone. The cloud will be responsible for storing the data and for performing the data preprocessing and analysis methods. Interventions primary outcome will be self-efficacy. Secondary outcomes will be womens weight, depression symptoms, quality of life, pregnancy anxiety, perceived stress, sence of coherence and acceptability, appropriateness and feasibility of Intervention.
Data will be collected via Oura smartring, electronic food diary and validated measures: Weight Efficacy Life-Style Questionnaire (WEL), Self-Efficacy for Physical Activity Scale (PASE), six-factor questionnaire (6-FQ), Three Factor Eating Questionnaire (TFEQ-R18), WHOQOL-BREF, Sense of coherence (SOC-13), Pregnancy anxiety (PRAQ-R2), Perceived stress and Edinburgh Postnatal Depression scale (EPDS). Intervention implementation will be evaluated with process evaluation. Data will be collected from public health nurses working in maternity clinics using focus group interviews and workshops.
Study Overview
Status
Intervention / Treatment
Detailed Description
Maternal obesity increases risks for the mother and her child. It is crucial to arouse the pregnant and postpartum women´s willingness of change and motivation to take care of their own and their unborn child´s health. Researchers have suggested that refining the pre-existing prenatal care models, possibly incorporating diet and physical activity into interventions, could be useful. Continuous monitoring can provide real-time information between scheduled appointments and thus may be helpful for targeting and tailoring pregnancy follow-up. Wearable devices can be helpful for weight-management, e.g. in improving participant's self-efficacy in making healthy behavior changes, improving self-awareness, in goal setting and getting feedback. However, it's very important to identify and tailor the intervention into individual motivations in order to facilitate technology adoption. Technological solutions designed for the pregnant women, can balance the gap between limited resources and growing demand of maternity care service. More comprehensive research is required to implement the optimal weight-management intervention for overweight women during pregnancy and the postpartum period and to develop appropriate and feasible implementation strategies to support nurses to deliver interventions in maternity clinics.
The aim of this study is to evaluate the effectiveness of the Supporting Lifestyle Change in Obese Pregnant Mothers Through Wearable Internet-of-Things (SLIM) intervention. Secondary aim is to evaluate the implementation of SLIM intervention in maternity care.
Intervention was developed based on findings of overweight women and their care givers interview study. In addition, intervention was planned in collaboration with public health nurses working in maternity clinics in workshops. The intervention targeting overweight pregnant women to improve their weight-management will be delivered during routine perinatal visits from the first visit to three months after child birth. Interventions core components will be goalsetting, motivational interviewing, feedback and health technology. Health technology includes Oura-ring and ZotCare -application. ZotCare -application combines data from Oura Smart Ring, electronic food diary and it´s also platform for researchers to send e.g. questionnaires and surveys to participants. Oura-smartring is an advanced technology ring that monitors e.g. heart rate, heart rate variability (HRV), steps, body temperature and sleep) and a smartphone application that includes data from Oura, and electronic food diary. Data collected with Oura -smartrings will be transmitted to cloud servers via a smartphone. The cloud will be responsible for storing the data and for performing the data preprocessing and analysis methods. Interventions primary outcome will be self-efficacy. Secondary outcomes will be womens weight, depression symptoms, quality of life and sence of coherence.
Data will be collected via Oura smartring, electronic food diary and validated measures: Weight Efficacy Life-Style Questionnaire (WEL), Self-Efficacy for Physical Activity Scale (PASE), six-factor questionnaire (6-FQ), Three Factor Eating Questionnaire (TFEQ-R18), WHOQOL-BREF, Sense of coherence (SOC-13), Pregnancy anxiety (PRAQ-R2), Perceived stress and Edinburgh Postnatal Depression scale (EPDS). Intervention implementation will be evaluated with process evaluation. Interventions acceptability, appropriateness and feasibility will be assessed with validated measures: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). Data will be collected from public health nurses working in maternity clinics using focus group interviews and workshops.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Johanna Saarikko, MNSc
- Phone Number: +358505701254
- Email: jpksaa@utu.fi
Study Locations
-
-
-
Loimaa, Finland
- Maternity care unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- pregnancy maximum 15 gestational weeks
- BMI >25
- finnish language
Exclusion Criteria:
- women who don´t have smart device
- severe mental illness (such as schizophrenia)
- diabetes mellitus type 1
- limitation of motility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention for overweight pregnant women
Intervention will be delivered during antenatal visits in maternity care
|
Core components: 1) goal setting, 2) motivational interviewing, 3) feedback, 4) health technology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of eating self-efficacy of overweight women
Time Frame: Change from first trimester Self-efficacy at third trimester and further at two months after delivery
|
Validated measurement tool: Weight Efficacy Life-Style Questionnaire (WEL) The 20-item questionnaire asks participants to rate their confidence in their ability to avoid eating on a 10-point Likert scale, 0 (not confident) to 9 (very confident). Scores range from 0 to 180 with higher scores indicating greater levels of self-efficacy. |
Change from first trimester Self-efficacy at third trimester and further at two months after delivery
|
Change of physical activity self-efficacy of overweight women
Time Frame: Change from first trimester Self-efficacy at third trimester and further at two months after delivery
|
Validated measurement tool: Self-Efficacy for Physical Activity Scale (PASE). The 5-item questionnaire asks participants to rate their confidence in their ability to regular physical activity on a 5-point Likert scale, 1 (not confident) to 5 (very confident). Scores range from 5 to 25 with higher scores indicating greater levels of self-efficacy. |
Change from first trimester Self-efficacy at third trimester and further at two months after delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight during pregnancy and after delivery
Time Frame: Through study completion, an average of 11 to 12 months.
|
Measurement: Womens weight (patient records)
|
Through study completion, an average of 11 to 12 months.
|
Change of depression symptoms of overweight women
Time Frame: From first trimester depression symptoms at third trimester and further at two months after delivery
|
Validated measurement tool: Perceived stress and Edinburgh Postnatal Depression scale (EPDS). The 10-item questionnaire asks participants to rate their depression symptoms on a 4-point Likert scale. Scores range from 0 to 30 with higher scores indicating greater levels of depression. |
From first trimester depression symptoms at third trimester and further at two months after delivery
|
Change of overweight womens quality of life
Time Frame: Change from first trimester quality of life at third trimester and further at two months after delivery
|
Validated measurement tool: WHO quality of life (WHOQOL-BREF). The 26-item questionnaire asks participants to rate their quality of life on a 5-point Likert scale, 1 to 5. Scores range from 0 to 100 with higher scores indicating better quality of life. |
Change from first trimester quality of life at third trimester and further at two months after delivery
|
Change of overweight womens sense of coherence
Time Frame: Change from first trimester sence of coherence at third trimester and further at two months after delivery
|
Validated measurement tool: Sense of coherence (SOC-13). The 13-item questionnaire asks participants to rate their sence of coherence on a 7-point Likert scale, 1 to 7. Higher scores indicate better sence of coherence. |
Change from first trimester sence of coherence at third trimester and further at two months after delivery
|
Change of pregnancy anxiety.
Time Frame: Change from first trimester anxiety at third trimester and further at two months after delivery
|
Validated tool: Pregnancy anxiety questionnaire-revised for all pregnant women regardless of parity:(PRAQ-R2) The 10-item questionnaire asks participants to rate their pregnancy anxiety on a 5-point Likert scale, 1 to 5. Higher scores indicate higher pregnancy anxiety. |
Change from first trimester anxiety at third trimester and further at two months after delivery
|
Change of perceived stress
Time Frame: Change from first trimester perceived stress at third trimester and further at two months after delivery
|
Validated tool: A global measure of perceived stress (original versions).
The 10-item questionnaire asks participants to rate their pregnancy anxiety on a 5-point Likert scale, 1 to 5. Higher scores indicate higher perceived stress.
|
Change from first trimester perceived stress at third trimester and further at two months after delivery
|
Interventions acceptability, appropriateness and feasibility
Time Frame: At gestational week 20, 34 and three months after delivery
|
Validated measures: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM). The 15-item questionnaire asks participants to rate interventions acceptability, appropriateness and feasibility on a 5-point Likert scale, 1 to 5. Higher scores indicate higher acceptability, appropriateness and feasibility. |
At gestational week 20, 34 and three months after delivery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hannakaisa Niela-vilen, PhD, University of Turku
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SLIM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight or Obesity
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Universidad Pablo de OlavideUniversity of SevilleCompletedObesity | Overweight and Obesity | Overweight or ObesitySpain
-
University of ChicagoNot yet recruitingOverweight or ObesityUnited States
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Hebei Medical University Third HospitalWestlake UniversityActive, not recruiting
-
PfizerCompleted
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
Clinical Trials on SLIM intervention
-
CochlearRecruitingSensorineural Hearing Loss | Low-Frequency Residual HearingUnited States
-
University of Santiago de CompostelaGalimplant Dental ImplantsCompletedDental Implant Failed | Dental Prosthesis FailureSpain
-
University of Santiago de CompostelaUniversidad de Murcia; University of Valencia; University of Salamanca; Health...Active, not recruitingDental Implant | Tooth Extraction | Tooth-loss | Teeth AbsentSpain
-
CochlearWithdrawnSensorineural Hearing Loss | Low-Frequency Residual HearingUnited States
-
Tissue Tech Inc.CompletedDry Eye DiseaseUnited States
-
Tissue Tech Inc.CompletedCorneal Dystrophy, Epithelial Basement MembraneUnited States
-
Wake Forest University Health SciencesCompleted
-
Duke Clergy Health InitiativeThe Duke EndowmentCompletedDepression | Hypertension | Obesity | Diabetes | HypercholesterolemiaUnited States
-
be MedicalBiolitec AGCompletedVaricose VeinsBelgium
-
Soonchunhyang University HospitalUnknownBile Duct Diseases | Biliary Tract Cancer | Common Bile Duct Calculi | Biliary StrictureKorea, Republic of